{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:09:52Z","timestamp":1784045392457,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canep.2026.103147","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:03:14Z","timestamp":1782493394000},"page":"103147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating level of Insulin-Like Growth Factors (IGFs) peptides and risk of colorectal adenoma and cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-9413","authenticated-orcid":false,"given":"Roberto","family":"Fabiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Chiavarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Giacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Rosignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canep.2026.103147_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"24","key":"10.1016\/j.canep.2026.103147_bib2","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3748\/wjg.v30.i24.3048","article-title":"Colorectal cancer screening: Modalities and adherence","volume":"30","author":"Metaxas","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.canep.2026.103147_bib3","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s43018-024-00841-x","article-title":"Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoids","volume":"5","author":"Mizutani","year":"2024","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib4","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i5.98629","article-title":"Risk factors, prevention and screening of colorectal cancer: A rising problem","volume":"31","author":"Tsukanov","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3892\/mmr.2025.13574","article-title":"Insulin-like growth factor in cancer: New perspectives (Review)","volume":"32","author":"Wu","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib6","first-page":"510","article-title":"The Prognostic Value of Combined LIN28B and IGF-1R in Colorectal Cancer","volume":"54","author":"Zhang","year":"2024","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib7","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0394","article-title":"Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome","volume":"30","author":"Laron","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canep.2026.103147_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.924952","article-title":"Acromegaly and Colorectal Neoplasm: An Update","volume":"13","author":"Kasuki","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnad008","article-title":"Signaling Pathways of the Insulin-like Growth Factor Binding Proteins","volume":"44","author":"Baxter","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.canep.2026.103147_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1730382","article-title":"Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer","volume":"15","author":"Fang","year":"2026","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/nu9040394","article-title":"Serum insulin-like growth factor axis and the risk of pancreatic cancer: systematic review and meta-analysis","volume":"9","author":"Gong","year":"2017","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14764","article-title":"Association of IGF-1 and IGFBP-3 levels with gastric cancer: A systematic review and meta-analysis","volume":"75","author":"Liu","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049884","article-title":"Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis","volume":"7","author":"Cao","year":"2012","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib14","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s11033-012-2432-z","article-title":"Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis","volume":"40","author":"Chi","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.canep.2026.103147_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.canep.2015.09.004","article-title":"Circulating levels of IGF-1, IGFBP-3, and IGF-1\/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis","volume":"39","author":"Yoon","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41598-024-52220-2","article-title":"Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.canep.2026.103147_bib17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2026.103147_bib18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2026.103147_bib19","article-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non Randomised Studies in Meta-Analyses","author":"Wells","year":"2000","journal-title":"Ott. Hosp. Res. Inst."},{"key":"10.1016\/j.canep.2026.103147_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.canep.2026.103147_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating Characteristics of a Rank Correlation Test for Publication Bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1016\/j.canep.2026.103147_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.canep.2026.103147_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y","article-title":"IGF-I and IGF-II in relation to colorectal cancer","volume":"83","author":"Manousos","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib26","first-page":"345","article-title":"A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women","volume":"9","author":"Giovannucci","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"19","key":"10.1016\/j.canep.2026.103147_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/jnci\/92.19.1592","article-title":"Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women","volume":"92","author":"Kaaks","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2168.2001.01645.x","article-title":"High-risk colorectal adenomas and serum insulin-like growth factors","volume":"88","author":"Renehan","year":"2001","journal-title":"Br. J. Surg."},{"issue":"17","key":"10.1016\/j.canep.2026.103147_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/93.17.1330","article-title":"Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men","volume":"93","author":"Ma","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib30","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1054\/bjoc.2001.2172","article-title":"IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai","volume":"85","author":"Probst-Hensch","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.50.5.642","article-title":"Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden","volume":"50","author":"Palmqvist","year":"2002","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib32","first-page":"901","article-title":"Insulin-like growth factor II and colorectal cancer risk in women","volume":"11","author":"Hunt","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1349-7006.2002.tb01222.x","article-title":"Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men","volume":"93","author":"Teramukai","year":"2002","journal-title":"Jpn J. Cancer Res."},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/aje\/kwg176","article-title":"Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men","volume":"158","author":"Nomura","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijc.11362","article-title":"Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden","volume":"107","author":"Palmqvist","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1055-9965.EPI-04-0661","article-title":"A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women","volume":"14","author":"Wei","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.gastro.2005.05.051","article-title":"Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps","volume":"129","author":"Schoen","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/1055-9965.EPI-05-0239","article-title":"Insulin resistance, apoptosis, and colorectal adenoma risk","volume":"14","author":"Keku","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1158\/1055-9965.EPI-05-0820","article-title":"C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women","volume":"15","author":"Wei","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.bjc.6603200","article-title":"Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies","volume":"95","author":"Morris","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib41","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ijc.22556","article-title":"Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study","volume":"120","author":"Otani","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.arcmed.2007.01.012","article-title":"Role of insulin-like growth factor-1 in colon cancerogenesis: a case-control study","volume":"38","author":"Tripkovic","year":"2007","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22697","article-title":"Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition","volume":"121","author":"Jenab","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/0008-5472.CAN-07-2946","article-title":"Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women","volume":"68","author":"Gunter","year":"2008","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canep.2026.103147_bib45","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1158\/1055-9965.EPI-08-0345","article-title":"IGF-I, IGFBP-3, and IGF-I\/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study","volume":"17","author":"Max","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2026.103147_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-8-143","article-title":"Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas","volume":"8","author":"Keku","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canep.2026.103147_bib47","first-page":"45","article-title":"Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study","volume":"10","author":"Suzuki","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"7","key":"10.1016\/j.canep.2026.103147_bib48","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.canep.2026.103147_bib49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1158\/1055-9965.EPI-10-0128","article-title":"Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population","volume":"19","author":"Le Marchand","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"12","key":"10.1016\/j.canep.2026.103147_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028520","article-title":"Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/1055-9965.EPI-11-1105","article-title":"Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study","volume":"21","author":"Ollberding","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib52","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1002\/ijc.26438","article-title":"Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma","volume":"131","author":"Gao","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2026.103147_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ijo.2011.114","article-title":"Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia","volume":"36","author":"Yamaji","year":"2012","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clinre.2013.06.004","article-title":"IGF-I levels and visceral fat accumulation in colonic neoplasia","volume":"38","author":"Erarslan","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib55","first-page":"161","article-title":"Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk","volume":"25","author":"Ochs-Balcom","year":"2014","journal-title":"Cancer Causes Control."},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib56","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1055-9965.EPI-14-0249-T","article-title":"Association of insulin-related serum factors with colorectal polyp number and type in adult males","volume":"23","author":"Comstock","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib57","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.7314\/APJCP.2015.16.9.3735","article-title":"Insulin-like growth factor-1, igf-binding protein-3, c-peptide and colorectal cancer: a case-control study","volume":"16","author":"Pankaj","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib58","first-page":"2959","article-title":"SNPs in the insulin-like growth factor gene and obesity impact on colorectal cancer in egyptians","volume":"18","author":"Yosry","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canep.2026.103147_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fendo.2018.00077","article-title":"Adiponectin, Leptin, IGF-1, and Tumor Necrosis Factor Alpha As Potential Serum Biomarkers for Non-Invasive Diagnosis of Colorectal Adenoma in African Americans","volume":"9","author":"Ashktorab","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.canep.2026.103147_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cen.13499","article-title":"Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1","volume":"88","author":"Chan","year":"2018","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"3","key":"10.1016\/j.canep.2026.103147_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz056","article-title":"Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp","volume":"3","author":"Hang","year":"2019","journal-title":"JNCI Cancer Spectr."},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib62","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/j.gastro.2019.12.020","article-title":"Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on Mendelian randomization and a meta-analysis","volume":"158","author":"Murphy","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib63","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.clnu.2019.12.005","article-title":"Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk","volume":"39","author":"Kim","year":"2020","journal-title":"Clin. Nutr."},{"issue":"18","key":"10.1016\/j.canep.2026.103147_bib64","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-1281","article-title":"Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank","volume":"80","author":"Knuppel","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.canep.2026.103147_bib65","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/codi.15360","article-title":"Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer","volume":"22","author":"Zeljkovic","year":"2020","journal-title":"Colorectal Dis."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10654-021-00811-y","article-title":"Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study","volume":"37","author":"Papier","year":"2022","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.canep.2026.103147_bib67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s43088-022-00254-8","article-title":"Linking insulin like growth factor-1 (IGF-1) rs6214 gene polymorphism and its serum level with risk of colorectal cancer","volume":"11","author":"Kattan","year":"2022","journal-title":"Beni-Suef Univ. J. Basic. Appl. Sci."},{"issue":"10","key":"10.1016\/j.canep.2026.103147_bib68","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1210\/clinem\/dgad212","article-title":"IGF-1 and Risk of Morbidity and Mortality From Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg","volume":"108","author":"Mukama","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.canep.2026.103147_bib69","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/biomedicines12081922","article-title":"Exploring Vitamin D Deficiency and IGF Axis Dynamics in Colorectal Adenomas","volume":"12","author":"Ciulei","year":"2024","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000545457","article-title":"Associations between Serum Insulin-Like Growth Factor-Related Molecules and Colorectal Cancer Risk by Tumor Location: A Nested Case-Control Study","volume":"106","author":"Adachi","year":"2025","journal-title":"Digestion"},{"key":"10.1016\/j.canep.2026.103147_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2026.102986","article-title":"Associations between insulin-like growth factor 1, IGF-binding protein 3, and colorectal cancer","volume":"100","author":"Lawler","year":"2026","journal-title":"Cancer Epidemiol."},{"issue":"7","key":"10.1016\/j.canep.2026.103147_bib72","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.apsb.2023.04.001","article-title":"Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I","volume":"13","author":"Xie","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.44.5.704","article-title":"Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon","volume":"44","author":"Freier","year":"1999","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.canep.2026.103147_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/mc.20577","article-title":"Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice","volume":"48","author":"Olivo-Marston","year":"2009","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.canep.2026.103147_bib75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12885-025-15496-9","article-title":"Circulating protein levels of insulin-like growth factor 1 signaling pathway and the predisposition to colorectal carcinogenesis: a systematic review and meta-analysis","volume":"26","author":"Naderi Noukabadi","year":"2025","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.canep.2026.103147_bib77","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/life12081274","article-title":"The insulin-like growth factor system and colorectal cancer","volume":"12","author":"Gligorijevi\u0107","year":"2022","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.canep.2026.103147_bib78","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.3390\/ijms25126400","article-title":"IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention-Results from Randomized Controlled Trials","volume":"25","author":"Meyer","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.canep.2026.103147_bib79","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0048","article-title":"Nutrition, GH\/IGF-1 signaling, and cancer","volume":"31","author":"Fanti","year":"2024","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2026.103147_bib80","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.3390\/ijms24054551","article-title":"The Impact of Westernization on the Insulin\/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change","volume":"24","author":"Janssen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canep.2026.103147_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102531","article-title":"Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: A systematic review and meta-analysis","volume":"102","author":"Rajakumar","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib82","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.canep.2026.103147_bib83","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s13760-025-02839-3","article-title":"Could serum IGF-1 and IGF-2 serve as potential biomarkers in idiopathic Parkinson's disease? A correlation with disease stages","volume":"125","author":"Cakir","year":"2025","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.canep.2026.103147_bib84","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.canep.2026.103147_bib85","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.canep.2026.103147_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-Binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.canep.2026.103147_bib87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fcell.2020.00286","article-title":"Insulin-Like growth factor binding protein-3 (igfbp-3): unraveling the role in mediating igf-independent effects within the cell","volume":"8","author":"Varma Shrivastav","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.canep.2026.103147_bib88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4274\/jcrpe.galenos.2019.2018.0277","article-title":"Evaluation of IGF1\/IGFBP3 molar ratio as an effective tool for assessing the safety of growth hormone therapy in small-for-gestational-age, growth hormone-deficient and prader-willi children","volume":"11","author":"Gaddas","year":"2019","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.canep.2026.103147_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/BIC.S23088","article-title":"Similarity of serum and plasma insulin-like growth factor concentrations","volume":"7","author":"Houghton","year":"2015","journal-title":"Biomark. Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:38:58Z","timestamp":1784043538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782126001633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":88,"alternative-id":["S1877782126001633"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.103147","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating level of Insulin-Like Growth Factors (IGFs) peptides and risk of colorectal adenoma and cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.103147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103147"}}